Modern immunotherapy of adult B-lineage acute lymphoblastic leukemia with monoclonal antibodies and chimeric antigen receptor modified T cells.
about
Minimal Residual Disease Monitoring in Adult ALL to Determine Therapy.Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment.Good Outcome for Very High Risk Adult B-cell Acute Lymphoblastic Leukaemia Carrying Genetic Abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if Promptly Submitted to Allogeneic Transplantation, after Obtaining a Good Molecular Remission.
P2860
Modern immunotherapy of adult B-lineage acute lymphoblastic leukemia with monoclonal antibodies and chimeric antigen receptor modified T cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Modern immunotherapy of adult ...... gen receptor modified T cells.
@en
type
label
Modern immunotherapy of adult ...... gen receptor modified T cells.
@en
prefLabel
Modern immunotherapy of adult ...... gen receptor modified T cells.
@en
P2093
P2860
P356
P1476
Modern immunotherapy of adult ...... gen receptor modified T cells.
@en
P2093
Anna Maria Scattolin
Anna Pascarella
Elena Maino
Michele Vespignani
Piera Viero
Renato Bassan
Rosaria Sancetta
P2860
P304
P356
10.4084/MJHID.2015.001
P577
2015-01-01T00:00:00Z